Endocrinology

Back to articles

Bisphosphonates linked to increased atrial fibrillation risk

KEY POINT

A new analysis of pooled data from nine studies, which included more than 135,000 patients, found that use of intravenous (IV) or oral bisphosphonates was associated with an increased risk of new-onset atrial fibrillation (AF), with the risk being higher in patients receiving IV therapy.